# Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis

> **NCT01825811** · PHASE2 · COMPLETED · sponsor: **Kolon Life Science** · enrollment: 18 (actual)

## Conditions studied

- Degenerative Arthritis

## Interventions

- **BIOLOGICAL:** TissueGene-C (Low dose)
- **BIOLOGICAL:** TissueGene-C (High dose)

## Key facts

- **NCT ID:** NCT01825811
- **Lead sponsor:** Kolon Life Science
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-04
- **Final completion:** 2014-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2015-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01825811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01825811, "Efficacy and Safety Study of TissueGene-C Mixed With Fibrin-glue for the Patients With Degenerative Arthritis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01825811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*